Not finding it? Sign in to also search OpenAlex live.
-
Early response by MR imaging and ultrasound as predictor of pathologic complete response to 12‐week neoadjuvant therapy for different early breast cancer subtypes: Combined analysis from the WSG ADAPT subtrials
Monika Graeser, Simone Schrading, Oleg Gluz, Kevin Strobel, Rachel Würstlein, Sherko Kümmel, +15 more
12citations -
Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: the multicentre prospective Safe Stop trial
Evalyn E.A.P. Mulder, Karlijn de Joode, Saskia Litière, Albert J. ten Tije, Karijn P.M. Suijkerbuijk, M. J. Boers‐Sonderen, +16 more
50citations -
[18F]FDG-PET/CT’s change in total lesion glycolysis can accurately identify early response upon neoadjuvant immunotherapy prior to curative-intent surgery in cutaneous squamous cell carcinoma; MATISSE trial2025 European Journal of Nuclear Medicine and Molecular Imaging article Medicine Nonmelanoma Skin Cancer Studies Open access
Sabine E. Breukers, Robert D. Crommelin, Laura A. Smit, Jan Paul de Boer, Arash Navran, Winan J. van Houdt, +6 more
2citations -
[18F]FDG-PET accurately identifies pathological response early upon neoadjuvant immune checkpoint blockade in head and neck squamous cell carcinoma2021 European Journal of Nuclear Medicine and Molecular Imaging article Medicine Medical Imaging Techniques and Applications Open access
Joris L. Vos, Charlotte L. Zuur, Laura A. Smit, Jan Paul de Boer, Abrahim A. Al-Mamgani, Michiel W. M. van den Brekel, +2 more
42citations -
Safe Stop IPI-NIVO trial: early discontinuation of nivolumab upon achieving a complete or partial response in patients with irresectable stage III or metastatic melanoma treated with first-line ipilimumab-nivolumab – study protocol
Brigit van Dijk, Karlijn de Joode, Maureen J.B. Aarts, Franchette W.P.J. van den Berkmortel, Christian U. Blank, M. J. Boers‐Sonderen, +15 more
7citations -
Baseline Interleukin‐10 Levels as a Predictive Biomarker for Achieving Clinical Response With Abatacept in Patients Who Were Disease‐Modifying Antirheumatic Drug Naive and Anti–Citrullinated Protein Antibody Positive With Early Rheumatoid Arthritis2026 Arthritis & Rheumatology article Medicine Rheumatoid Arthritis Research and Therapies Open access
Jinqi Liu, Y. Li, Kai Fu, Chun Wu, Peter H Schafer, S. Connolly, +9 more
0citations -
Baseline serum levels of cross-linked carboxy-terminal telopeptide of type I collagen predict abatacept treatment response in methotrexate-naive, anticitrullinated protein antibody-positive patients with early rheumatoid arthritis
Chun‐Ying Wu, Yanhua Hu, Peter H Schafer, Seán Connolly, Robert L. Wong, Signe Holm Nielsen, +8 more
4citations -
Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer2023 Journal of Clinical Oncology article Medicine Endometrial and Cervical Cancer Treatments Open access
Nanda Horeweg, Remi A. Nout, Ina Maria Jurgenliemk-Schulz, Ludy C.H.W. Lutgens, Jan J. Jobsen, Marie A.D. Haverkort, +38 more
104citations -
The trajectory of clinical responses in patients with early rheumatoid arthritis who achieve sustained remission in response to abatacept: subanalysis of AVERT-2, a randomized phase IIIb study2023 Arthritis Research & Therapy article Medicine Rheumatoid Arthritis Research and Therapies Open access
Paul E. Emery, Yoshiya Tanaka, Vivian P. Bykerk, Clifton O. Bingham, Gustavo Citera, Kuan‐Hsiang Gary Huang, +6 more
4citations -
Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer2021 Clinical Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Bruno Valentin Sinn, Sibylle Loibl, Claus Alexander Hanusch, Dirk-Michael Zahm, Hans‐Peter Sinn, Michael Untch, +16 more
46citations -
Value of MRI and ultrasound for prediction of therapeutic response and erosive progression in patients with early rheumatoid arthritis managed by an aggressive treat-to-target strategy
Ulf Sundin, Nina Paulshus Sundlisæter, Anna‐Birgitte Aga, Joseph Sexton, Lena Bugge Nordberg, Hilde Berner Hammer, +4 more
29citations -
Hand-dominant joint involvement pattern associates with favourable, and polyarthritis with unfavourable, treatment response to both csDMARDs and bDMARDs in early rheumatoid arthritis: a combined analysis of NORD-STAR and BeSt trials2026 Annals of the Rheumatic Diseases article Medicine Rheumatoid Arthritis Research and Therapies Open access
Yasuo Nagafuchi, Tjardo Daniël Maarseveen, Kristina Lend, Anna Rudin, Björn Guðbjörnsson, Dan Nordström, +15 more
0citations -
Early DAS response after DMARD-start increases probability of achieving sustained DMARD-free remission in rheumatoid arthritis2020 Arthritis Research & Therapy article Medicine Rheumatoid Arthritis Research and Therapies Open access
Marloes Verstappen, Ellis Niemantsverdriet, X. Matthijssen, Saskia le Cessie, Annette H M van der Helm–van Mil
22citations -
Baseline and early digital [18F]FDG PET/CT and multiparametric MRI contain promising features to predict response to neoadjuvant therapy in locally advanced rectal cancer patients: a pilot study
Floris A. Vuijk, Shirin Feshtali Shahbazi, Wyanne A. Noortman, Floris H. P. van Velden, Petra Dibbets‐Schneider, Andreas W. K. S. Marinelli, +13 more
4citations -
Early response evaluation using 18F-FDG-PET/CT does not influence management of patients with metastatic gastrointestinal stromal tumors (GIST) treated with palliative intent2021 Nuklearmedizin - NuclearMedicine article Medicine Gastrointestinal Tumor Research and Treatment Open access
Sheima Farag, Nikki S. IJzerman, Matthijs P.M. Houdijk, Anna K.L. Reyners, Anne I.J. Arens, Dirk Jan Grünhagen, +4 more
4citations -
Tumor‐stroma ratio is associated with Miller‐Payne score and pathological response to neoadjuvant chemotherapy in HER2 ‐negative early breast cancer2021 International Journal of Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Sophie C. Hagenaars, Stefanie de Groot, Danielle B. Cohen, Tim J. A. Dekker, Ayoub Charehbili, Elma Meershoek‐Klein Kranenbarg, +6 more
43citations -
Item response theory in early phase clinical trials: Utilization of a reference model to analyze the Montgomery‐Åsberg Depression Rating Scale2023 CPT Pharmacometrics & Systems Pharmacology article Decision Sciences Psychometric Methodologies and Testing Open access cited by 1 patent
Marije E. Otto, Kirsten Riber Bergmann, Marieke L. de Kam, Kasper Recourt, Gabriël E. Jacobs, Michiel Joost van Esdonk
3citations